Literature DB >> 12458149

An overview of the pathogenesis of cystic fibrosis lung disease.

R C Boucher1.   

Abstract

The pathogenesis of cystic fibrosis (CF) lung disease is reviewed, focusing on an overview of the physiologic mechanisms that regulate mucus transport. A major emphasis is placed on the active transport systems that regulate the airway surface liquid (ASL) volume and, particularly, regulate the volume of the periciliary liquid (PCL) layer. A sequence is developed for CF whereby there is a depletion of the PCL that reflects the combined dysfunctions of accelerated Na(+)-dependent volume absorption and failure to secrete Cl(-). Both dysfunctions are a direct consequence of missing cystic fibrosis transmembrane conductance regulator (CFTR) at the apical membrane of airway epithelial cells. PCL depletion leads to failure of mucus transport, which is associated with persistent mucin secretion and formation of adherent mucus plaques and plugs. These plugs become the nidus for persistent bacterial airway infections that ultimately lead to a markedly anaerobic luminal environment. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458149     DOI: 10.1016/s0169-409x(02)00144-8

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  70 in total

1.  Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life.

Authors:  Matthew R Parsek; Clay Fuqua
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

2.  Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic Effect.

Authors:  Timothy E Corcoran; Alex S Huber; Michael M Myerburg; Daniel J Weiner; Landon W Locke; Ryan T Lacy; Lawrence Weber; Michael R Czachowski; Darragh J Johnston; Ashok Muthukrishnan; Alison T Lennox; Joseph M Pilewski
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-04-10       Impact factor: 2.849

Review 3.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

Review 4.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

5.  Spatial Mapping of Pyocyanin in Pseudomonas Aeruginosa Bacterial Communities Using Surface Enhanced Raman Scattering.

Authors:  Sneha Polisetti; Nameera F Baig; Nydia Morales-Soto; Joshua D Shrout; Paul W Bohn
Journal:  Appl Spectrosc       Date:  2016-07-20       Impact factor: 2.388

6.  Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa.

Authors:  Arvind Venkataraman; Miriam A Rosenbaum; Jeffrey J Werner; Stephen C Winans; Largus T Angenent
Journal:  ISME J       Date:  2014-01-09       Impact factor: 10.302

7.  Genotype-phenotype correlation for pulmonary function in cystic fibrosis.

Authors:  J de Gracia; F Mata; A Alvarez; T Casals; S Gatner; M Vendrell; D de la Rosa; L Guarner; E Hermosilla
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

8.  Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.

Authors:  William B Guggino; Liudmila Cebotaru
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

9.  Polarized secretion of interleukin (IL)-6 and IL-8 by human airway epithelia 16HBE14o- cells in response to cationic polypeptide challenge.

Authors:  Alison Wai-ming Chow; Jocelyn Feng-ting Liang; Janice Siu-chong Wong; Yan Fu; Nelson Leung-sang Tang; Wing-hung Ko
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

Review 10.  Purinergic receptors in airway epithelia.

Authors:  Eduardo R Lazarowski; Richard C Boucher
Journal:  Curr Opin Pharmacol       Date:  2009-03-13       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.